Global Foot and Mouth Disease (FMD) Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Foot and Mouth Disease (FMD) Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 128

Published Date: 18 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

According to our (Global Info Research) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at USD 1076.3 million in 2022 and is forecast to a readjusted size of USD 1991.3 million by 2029 with a CAGR of 9.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.

Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.

In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.

This report is a detailed and comprehensive analysis for global Foot and Mouth Disease (FMD) Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Foot and Mouth Disease (FMD) Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2018-2029
Global Foot and Mouth Disease (FMD) Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2018-2029
Global Foot and Mouth Disease (FMD) Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2018-2029
Global Foot and Mouth Disease (FMD) Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/K Doses), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Foot and Mouth Disease (FMD) Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Foot and Mouth Disease (FMD) Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jinyu Group, Cavet Bio, Indian Immunologicals, Tecon Group and CAHIC, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Foot and Mouth Disease (FMD) Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Emergency Vaccines
Conventional Vaccines

Market segment by Application
Cattle
Pig
Sheep and Goat
Others

Major players covered
Jinyu Group
Cavet Bio
Indian Immunologicals
Tecon Group
CAHIC
Shen Lian
Biogenesis Bagó
BIGVET Biotech
Boehringer Ingelheim
MSD Animal Health
CEVA
FGBI
Bayer HealthCare
Brilliant Bio Pharma
VECOL
Sanofi (Merial)
VETAL
BVI
LIMOR
ME VAC
Agrovet

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Foot and Mouth Disease (FMD) Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Foot and Mouth Disease (FMD) Vaccines, with price, sales, revenue and global market share of Foot and Mouth Disease (FMD) Vaccines from 2018 to 2023.
Chapter 3, the Foot and Mouth Disease (FMD) Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Foot and Mouth Disease (FMD) Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Foot and Mouth Disease (FMD) Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Foot and Mouth Disease (FMD) Vaccines.
Chapter 14 and 15, to describe Foot and Mouth Disease (FMD) Vaccines sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Foot and Mouth Disease (FMD) Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Emergency Vaccines
1.3.3 Conventional Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cattle
1.4.3 Pig
1.4.4 Sheep and Goat
1.4.5 Others
1.5 Global Foot and Mouth Disease (FMD) Vaccines Market Size & Forecast
1.5.1 Global Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity (2018-2029)
1.5.3 Global Foot and Mouth Disease (FMD) Vaccines Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Jinyu Group
2.1.1 Jinyu Group Details
2.1.2 Jinyu Group Major Business
2.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product and Services
2.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Jinyu Group Recent Developments/Updates
2.2 Cavet Bio
2.2.1 Cavet Bio Details
2.2.2 Cavet Bio Major Business
2.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product and Services
2.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Cavet Bio Recent Developments/Updates
2.3 Indian Immunologicals
2.3.1 Indian Immunologicals Details
2.3.2 Indian Immunologicals Major Business
2.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product and Services
2.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Indian Immunologicals Recent Developments/Updates
2.4 Tecon Group
2.4.1 Tecon Group Details
2.4.2 Tecon Group Major Business
2.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Product and Services
2.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Tecon Group Recent Developments/Updates
2.5 CAHIC
2.5.1 CAHIC Details
2.5.2 CAHIC Major Business
2.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Product and Services
2.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CAHIC Recent Developments/Updates
2.6 Shen Lian
2.6.1 Shen Lian Details
2.6.2 Shen Lian Major Business
2.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Product and Services
2.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Shen Lian Recent Developments/Updates
2.7 Biogenesis Bagó
2.7.1 Biogenesis Bagó Details
2.7.2 Biogenesis Bagó Major Business
2.7.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product and Services
2.7.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Biogenesis Bagó Recent Developments/Updates
2.8 BIGVET Biotech
2.8.1 BIGVET Biotech Details
2.8.2 BIGVET Biotech Major Business
2.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product and Services
2.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 BIGVET Biotech Recent Developments/Updates
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product and Services
2.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Boehringer Ingelheim Recent Developments/Updates
2.10 MSD Animal Health
2.10.1 MSD Animal Health Details
2.10.2 MSD Animal Health Major Business
2.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product and Services
2.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 MSD Animal Health Recent Developments/Updates
2.11 CEVA
2.11.1 CEVA Details
2.11.2 CEVA Major Business
2.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Product and Services
2.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CEVA Recent Developments/Updates
2.12 FGBI
2.12.1 FGBI Details
2.12.2 FGBI Major Business
2.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Product and Services
2.12.4 FGBI Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 FGBI Recent Developments/Updates
2.13 Bayer HealthCare
2.13.1 Bayer HealthCare Details
2.13.2 Bayer HealthCare Major Business
2.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product and Services
2.13.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Bayer HealthCare Recent Developments/Updates
2.14 Brilliant Bio Pharma
2.14.1 Brilliant Bio Pharma Details
2.14.2 Brilliant Bio Pharma Major Business
2.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product and Services
2.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Brilliant Bio Pharma Recent Developments/Updates
2.15 VECOL
2.15.1 VECOL Details
2.15.2 VECOL Major Business
2.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Product and Services
2.15.4 VECOL Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 VECOL Recent Developments/Updates
2.16 Sanofi (Merial)
2.16.1 Sanofi (Merial) Details
2.16.2 Sanofi (Merial) Major Business
2.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product and Services
2.16.4 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Sanofi (Merial) Recent Developments/Updates
2.17 VETAL
2.17.1 VETAL Details
2.17.2 VETAL Major Business
2.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Product and Services
2.17.4 VETAL Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 VETAL Recent Developments/Updates
2.18 BVI
2.18.1 BVI Details
2.18.2 BVI Major Business
2.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Product and Services
2.18.4 BVI Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 BVI Recent Developments/Updates
2.19 LIMOR
2.19.1 LIMOR Details
2.19.2 LIMOR Major Business
2.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Product and Services
2.19.4 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 LIMOR Recent Developments/Updates
2.20 ME VAC
2.20.1 ME VAC Details
2.20.2 ME VAC Major Business
2.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Product and Services
2.20.4 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 ME VAC Recent Developments/Updates
2.21 Agrovet
2.21.1 Agrovet Details
2.21.2 Agrovet Major Business
2.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Product and Services
2.21.4 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Agrovet Recent Developments/Updates

3 Competitive Environment: Foot and Mouth Disease (FMD) Vaccines by Manufacturer
3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Foot and Mouth Disease (FMD) Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Foot and Mouth Disease (FMD) Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Foot and Mouth Disease (FMD) Vaccines Manufacturer Market Share in 2022
3.5 Foot and Mouth Disease (FMD) Vaccines Market: Overall Company Footprint Analysis
3.5.1 Foot and Mouth Disease (FMD) Vaccines Market: Region Footprint
3.5.2 Foot and Mouth Disease (FMD) Vaccines Market: Company Product Type Footprint
3.5.3 Foot and Mouth Disease (FMD) Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region
4.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Region (2018-2029)
4.2 North America Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029)
4.3 Europe Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029)
4.5 South America Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Type (2018-2029)
5.3 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Application (2018-2029)
6.3 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Application (2018-2029)

7 North America
7.1 North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Country
7.3.1 North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Country
8.3.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Region
9.3.1 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Foot and Mouth Disease (FMD) Vaccines Market Size by Country
10.3.1 South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Country
11.3.1 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Foot and Mouth Disease (FMD) Vaccines Market Drivers
12.2 Foot and Mouth Disease (FMD) Vaccines Market Restraints
12.3 Foot and Mouth Disease (FMD) Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Foot and Mouth Disease (FMD) Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Foot and Mouth Disease (FMD) Vaccines
13.3 Foot and Mouth Disease (FMD) Vaccines Production Process
13.4 Foot and Mouth Disease (FMD) Vaccines Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Foot and Mouth Disease (FMD) Vaccines Typical Distributors
14.3 Foot and Mouth Disease (FMD) Vaccines Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Jinyu Group Basic Information, Manufacturing Base and Competitors
Table 4. Jinyu Group Major Business
Table 5. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 6. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Jinyu Group Recent Developments/Updates
Table 8. Cavet Bio Basic Information, Manufacturing Base and Competitors
Table 9. Cavet Bio Major Business
Table 10. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 11. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Cavet Bio Recent Developments/Updates
Table 13. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 14. Indian Immunologicals Major Business
Table 15. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 16. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Indian Immunologicals Recent Developments/Updates
Table 18. Tecon Group Basic Information, Manufacturing Base and Competitors
Table 19. Tecon Group Major Business
Table 20. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 21. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Tecon Group Recent Developments/Updates
Table 23. CAHIC Basic Information, Manufacturing Base and Competitors
Table 24. CAHIC Major Business
Table 25. CAHIC Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 26. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. CAHIC Recent Developments/Updates
Table 28. Shen Lian Basic Information, Manufacturing Base and Competitors
Table 29. Shen Lian Major Business
Table 30. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 31. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Shen Lian Recent Developments/Updates
Table 33. Biogenesis Bagó Basic Information, Manufacturing Base and Competitors
Table 34. Biogenesis Bagó Major Business
Table 35. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 36. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Biogenesis Bagó Recent Developments/Updates
Table 38. BIGVET Biotech Basic Information, Manufacturing Base and Competitors
Table 39. BIGVET Biotech Major Business
Table 40. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 41. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. BIGVET Biotech Recent Developments/Updates
Table 43. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer Ingelheim Major Business
Table 45. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 46. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Boehringer Ingelheim Recent Developments/Updates
Table 48. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 49. MSD Animal Health Major Business
Table 50. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 51. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. MSD Animal Health Recent Developments/Updates
Table 53. CEVA Basic Information, Manufacturing Base and Competitors
Table 54. CEVA Major Business
Table 55. CEVA Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 56. CEVA Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. CEVA Recent Developments/Updates
Table 58. FGBI Basic Information, Manufacturing Base and Competitors
Table 59. FGBI Major Business
Table 60. FGBI Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 61. FGBI Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. FGBI Recent Developments/Updates
Table 63. Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table 64. Bayer HealthCare Major Business
Table 65. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 66. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Bayer HealthCare Recent Developments/Updates
Table 68. Brilliant Bio Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Brilliant Bio Pharma Major Business
Table 70. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 71. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Brilliant Bio Pharma Recent Developments/Updates
Table 73. VECOL Basic Information, Manufacturing Base and Competitors
Table 74. VECOL Major Business
Table 75. VECOL Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 76. VECOL Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. VECOL Recent Developments/Updates
Table 78. Sanofi (Merial) Basic Information, Manufacturing Base and Competitors
Table 79. Sanofi (Merial) Major Business
Table 80. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 81. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Sanofi (Merial) Recent Developments/Updates
Table 83. VETAL Basic Information, Manufacturing Base and Competitors
Table 84. VETAL Major Business
Table 85. VETAL Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 86. VETAL Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. VETAL Recent Developments/Updates
Table 88. BVI Basic Information, Manufacturing Base and Competitors
Table 89. BVI Major Business
Table 90. BVI Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 91. BVI Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. BVI Recent Developments/Updates
Table 93. LIMOR Basic Information, Manufacturing Base and Competitors
Table 94. LIMOR Major Business
Table 95. LIMOR Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 96. LIMOR Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. LIMOR Recent Developments/Updates
Table 98. ME VAC Basic Information, Manufacturing Base and Competitors
Table 99. ME VAC Major Business
Table 100. ME VAC Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 101. ME VAC Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. ME VAC Recent Developments/Updates
Table 103. Agrovet Basic Information, Manufacturing Base and Competitors
Table 104. Agrovet Major Business
Table 105. Agrovet Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 106. Agrovet Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Agrovet Recent Developments/Updates
Table 108. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Manufacturer (2018-2023) & (M Doses)
Table 109. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 110. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Manufacturer (2018-2023) & (USD/K Doses)
Table 111. Market Position of Manufacturers in Foot and Mouth Disease (FMD) Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 112. Head Office and Foot and Mouth Disease (FMD) Vaccines Production Site of Key Manufacturer
Table 113. Foot and Mouth Disease (FMD) Vaccines Market: Company Product Type Footprint
Table 114. Foot and Mouth Disease (FMD) Vaccines Market: Company Product Application Footprint
Table 115. Foot and Mouth Disease (FMD) Vaccines New Market Entrants and Barriers to Market Entry
Table 116. Foot and Mouth Disease (FMD) Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 117. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 118. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 119. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 120. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 121. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Region (2018-2023) & (USD/K Doses)
Table 122. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Region (2024-2029) & (USD/K Doses)
Table 123. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 124. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 125. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 126. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 127. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Type (2018-2023) & (USD/K Doses)
Table 128. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Type (2024-2029) & (USD/K Doses)
Table 129. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 130. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 131. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 132. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 133. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Application (2018-2023) & (USD/K Doses)
Table 134. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Application (2024-2029) & (USD/K Doses)
Table 135. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 136. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 137. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 138. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 139. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 140. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 141. North America Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 142. North America Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 143. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 144. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 145. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 146. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 147. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 148. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 149. Europe Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 150. Europe Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 151. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 152. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 153. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 154. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 155. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 156. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 157. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 158. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 159. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 160. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 161. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 162. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 163. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 164. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 165. South America Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 166. South America Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 167. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 168. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 169. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 170. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 171. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 172. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 173. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 174. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 175. Foot and Mouth Disease (FMD) Vaccines Raw Material
Table 176. Key Manufacturers of Foot and Mouth Disease (FMD) Vaccines Raw Materials
Table 177. Foot and Mouth Disease (FMD) Vaccines Typical Distributors
Table 178. Foot and Mouth Disease (FMD) Vaccines Typical Customers
List of Figures
Figure 1. Foot and Mouth Disease (FMD) Vaccines Picture
Figure 2. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Emergency Vaccines Examples
Figure 5. Conventional Vaccines Examples
Figure 6. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Application in 2022
Figure 8. Cattle Examples
Figure 9. Pig Examples
Figure 10. Sheep and Goat Examples
Figure 11. Others Examples
Figure 12. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity (2018-2029) & (M Doses)
Figure 15. Global Foot and Mouth Disease (FMD) Vaccines Average Price (2018-2029) & (USD/K Doses)
Figure 16. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Foot and Mouth Disease (FMD) Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Foot and Mouth Disease (FMD) Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Foot and Mouth Disease (FMD) Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Type (2018-2029) & (USD/K Doses)
Figure 31. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Application (2018-2029) & (USD/K Doses)
Figure 34. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 54. China Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Foot and Mouth Disease (FMD) Vaccines Market Drivers
Figure 75. Foot and Mouth Disease (FMD) Vaccines Market Restraints
Figure 76. Foot and Mouth Disease (FMD) Vaccines Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Foot and Mouth Disease (FMD) Vaccines in 2022
Figure 79. Manufacturing Process Analysis of Foot and Mouth Disease (FMD) Vaccines
Figure 80. Foot and Mouth Disease (FMD) Vaccines Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Foot and Mouth Disease (FMD) Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Foot and Mouth Disease (FMD) Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 128

Published Date: 18 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

According to our (Global Info Research) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at USD 1076.3 million in 2022 and is forecast to a readjusted size of USD 1991.3 million by 2029 with a CAGR of 9.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.

Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.

In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.

This report is a detailed and comprehensive analysis for global Foot and Mouth Disease (FMD) Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Foot and Mouth Disease (FMD) Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2018-2029
Global Foot and Mouth Disease (FMD) Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2018-2029
Global Foot and Mouth Disease (FMD) Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2018-2029
Global Foot and Mouth Disease (FMD) Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/K Doses), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Foot and Mouth Disease (FMD) Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Foot and Mouth Disease (FMD) Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jinyu Group, Cavet Bio, Indian Immunologicals, Tecon Group and CAHIC, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Foot and Mouth Disease (FMD) Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Emergency Vaccines
Conventional Vaccines

Market segment by Application
Cattle
Pig
Sheep and Goat
Others

Major players covered
Jinyu Group
Cavet Bio
Indian Immunologicals
Tecon Group
CAHIC
Shen Lian
Biogenesis Bagó
BIGVET Biotech
Boehringer Ingelheim
MSD Animal Health
CEVA
FGBI
Bayer HealthCare
Brilliant Bio Pharma
VECOL
Sanofi (Merial)
VETAL
BVI
LIMOR
ME VAC
Agrovet

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Foot and Mouth Disease (FMD) Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Foot and Mouth Disease (FMD) Vaccines, with price, sales, revenue and global market share of Foot and Mouth Disease (FMD) Vaccines from 2018 to 2023.
Chapter 3, the Foot and Mouth Disease (FMD) Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Foot and Mouth Disease (FMD) Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Foot and Mouth Disease (FMD) Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Foot and Mouth Disease (FMD) Vaccines.
Chapter 14 and 15, to describe Foot and Mouth Disease (FMD) Vaccines sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Foot and Mouth Disease (FMD) Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Emergency Vaccines
1.3.3 Conventional Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cattle
1.4.3 Pig
1.4.4 Sheep and Goat
1.4.5 Others
1.5 Global Foot and Mouth Disease (FMD) Vaccines Market Size & Forecast
1.5.1 Global Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity (2018-2029)
1.5.3 Global Foot and Mouth Disease (FMD) Vaccines Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Jinyu Group
2.1.1 Jinyu Group Details
2.1.2 Jinyu Group Major Business
2.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product and Services
2.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Jinyu Group Recent Developments/Updates
2.2 Cavet Bio
2.2.1 Cavet Bio Details
2.2.2 Cavet Bio Major Business
2.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product and Services
2.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Cavet Bio Recent Developments/Updates
2.3 Indian Immunologicals
2.3.1 Indian Immunologicals Details
2.3.2 Indian Immunologicals Major Business
2.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product and Services
2.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Indian Immunologicals Recent Developments/Updates
2.4 Tecon Group
2.4.1 Tecon Group Details
2.4.2 Tecon Group Major Business
2.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Product and Services
2.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Tecon Group Recent Developments/Updates
2.5 CAHIC
2.5.1 CAHIC Details
2.5.2 CAHIC Major Business
2.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Product and Services
2.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CAHIC Recent Developments/Updates
2.6 Shen Lian
2.6.1 Shen Lian Details
2.6.2 Shen Lian Major Business
2.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Product and Services
2.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Shen Lian Recent Developments/Updates
2.7 Biogenesis Bagó
2.7.1 Biogenesis Bagó Details
2.7.2 Biogenesis Bagó Major Business
2.7.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product and Services
2.7.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Biogenesis Bagó Recent Developments/Updates
2.8 BIGVET Biotech
2.8.1 BIGVET Biotech Details
2.8.2 BIGVET Biotech Major Business
2.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product and Services
2.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 BIGVET Biotech Recent Developments/Updates
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product and Services
2.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Boehringer Ingelheim Recent Developments/Updates
2.10 MSD Animal Health
2.10.1 MSD Animal Health Details
2.10.2 MSD Animal Health Major Business
2.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product and Services
2.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 MSD Animal Health Recent Developments/Updates
2.11 CEVA
2.11.1 CEVA Details
2.11.2 CEVA Major Business
2.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Product and Services
2.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CEVA Recent Developments/Updates
2.12 FGBI
2.12.1 FGBI Details
2.12.2 FGBI Major Business
2.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Product and Services
2.12.4 FGBI Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 FGBI Recent Developments/Updates
2.13 Bayer HealthCare
2.13.1 Bayer HealthCare Details
2.13.2 Bayer HealthCare Major Business
2.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product and Services
2.13.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Bayer HealthCare Recent Developments/Updates
2.14 Brilliant Bio Pharma
2.14.1 Brilliant Bio Pharma Details
2.14.2 Brilliant Bio Pharma Major Business
2.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product and Services
2.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Brilliant Bio Pharma Recent Developments/Updates
2.15 VECOL
2.15.1 VECOL Details
2.15.2 VECOL Major Business
2.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Product and Services
2.15.4 VECOL Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 VECOL Recent Developments/Updates
2.16 Sanofi (Merial)
2.16.1 Sanofi (Merial) Details
2.16.2 Sanofi (Merial) Major Business
2.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product and Services
2.16.4 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Sanofi (Merial) Recent Developments/Updates
2.17 VETAL
2.17.1 VETAL Details
2.17.2 VETAL Major Business
2.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Product and Services
2.17.4 VETAL Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 VETAL Recent Developments/Updates
2.18 BVI
2.18.1 BVI Details
2.18.2 BVI Major Business
2.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Product and Services
2.18.4 BVI Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 BVI Recent Developments/Updates
2.19 LIMOR
2.19.1 LIMOR Details
2.19.2 LIMOR Major Business
2.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Product and Services
2.19.4 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 LIMOR Recent Developments/Updates
2.20 ME VAC
2.20.1 ME VAC Details
2.20.2 ME VAC Major Business
2.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Product and Services
2.20.4 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 ME VAC Recent Developments/Updates
2.21 Agrovet
2.21.1 Agrovet Details
2.21.2 Agrovet Major Business
2.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Product and Services
2.21.4 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Agrovet Recent Developments/Updates

3 Competitive Environment: Foot and Mouth Disease (FMD) Vaccines by Manufacturer
3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Foot and Mouth Disease (FMD) Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Foot and Mouth Disease (FMD) Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Foot and Mouth Disease (FMD) Vaccines Manufacturer Market Share in 2022
3.5 Foot and Mouth Disease (FMD) Vaccines Market: Overall Company Footprint Analysis
3.5.1 Foot and Mouth Disease (FMD) Vaccines Market: Region Footprint
3.5.2 Foot and Mouth Disease (FMD) Vaccines Market: Company Product Type Footprint
3.5.3 Foot and Mouth Disease (FMD) Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region
4.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Region (2018-2029)
4.2 North America Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029)
4.3 Europe Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029)
4.5 South America Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Type (2018-2029)
5.3 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Application (2018-2029)
6.3 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Application (2018-2029)

7 North America
7.1 North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Country
7.3.1 North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Country
8.3.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Region
9.3.1 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Foot and Mouth Disease (FMD) Vaccines Market Size by Country
10.3.1 South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Country
11.3.1 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Foot and Mouth Disease (FMD) Vaccines Market Drivers
12.2 Foot and Mouth Disease (FMD) Vaccines Market Restraints
12.3 Foot and Mouth Disease (FMD) Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Foot and Mouth Disease (FMD) Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Foot and Mouth Disease (FMD) Vaccines
13.3 Foot and Mouth Disease (FMD) Vaccines Production Process
13.4 Foot and Mouth Disease (FMD) Vaccines Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Foot and Mouth Disease (FMD) Vaccines Typical Distributors
14.3 Foot and Mouth Disease (FMD) Vaccines Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Jinyu Group Basic Information, Manufacturing Base and Competitors
Table 4. Jinyu Group Major Business
Table 5. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 6. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Jinyu Group Recent Developments/Updates
Table 8. Cavet Bio Basic Information, Manufacturing Base and Competitors
Table 9. Cavet Bio Major Business
Table 10. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 11. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Cavet Bio Recent Developments/Updates
Table 13. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 14. Indian Immunologicals Major Business
Table 15. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 16. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Indian Immunologicals Recent Developments/Updates
Table 18. Tecon Group Basic Information, Manufacturing Base and Competitors
Table 19. Tecon Group Major Business
Table 20. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 21. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Tecon Group Recent Developments/Updates
Table 23. CAHIC Basic Information, Manufacturing Base and Competitors
Table 24. CAHIC Major Business
Table 25. CAHIC Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 26. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. CAHIC Recent Developments/Updates
Table 28. Shen Lian Basic Information, Manufacturing Base and Competitors
Table 29. Shen Lian Major Business
Table 30. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 31. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Shen Lian Recent Developments/Updates
Table 33. Biogenesis Bagó Basic Information, Manufacturing Base and Competitors
Table 34. Biogenesis Bagó Major Business
Table 35. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 36. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Biogenesis Bagó Recent Developments/Updates
Table 38. BIGVET Biotech Basic Information, Manufacturing Base and Competitors
Table 39. BIGVET Biotech Major Business
Table 40. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 41. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. BIGVET Biotech Recent Developments/Updates
Table 43. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer Ingelheim Major Business
Table 45. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 46. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Boehringer Ingelheim Recent Developments/Updates
Table 48. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 49. MSD Animal Health Major Business
Table 50. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 51. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. MSD Animal Health Recent Developments/Updates
Table 53. CEVA Basic Information, Manufacturing Base and Competitors
Table 54. CEVA Major Business
Table 55. CEVA Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 56. CEVA Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. CEVA Recent Developments/Updates
Table 58. FGBI Basic Information, Manufacturing Base and Competitors
Table 59. FGBI Major Business
Table 60. FGBI Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 61. FGBI Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. FGBI Recent Developments/Updates
Table 63. Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table 64. Bayer HealthCare Major Business
Table 65. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 66. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Bayer HealthCare Recent Developments/Updates
Table 68. Brilliant Bio Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Brilliant Bio Pharma Major Business
Table 70. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 71. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Brilliant Bio Pharma Recent Developments/Updates
Table 73. VECOL Basic Information, Manufacturing Base and Competitors
Table 74. VECOL Major Business
Table 75. VECOL Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 76. VECOL Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. VECOL Recent Developments/Updates
Table 78. Sanofi (Merial) Basic Information, Manufacturing Base and Competitors
Table 79. Sanofi (Merial) Major Business
Table 80. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 81. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Sanofi (Merial) Recent Developments/Updates
Table 83. VETAL Basic Information, Manufacturing Base and Competitors
Table 84. VETAL Major Business
Table 85. VETAL Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 86. VETAL Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. VETAL Recent Developments/Updates
Table 88. BVI Basic Information, Manufacturing Base and Competitors
Table 89. BVI Major Business
Table 90. BVI Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 91. BVI Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. BVI Recent Developments/Updates
Table 93. LIMOR Basic Information, Manufacturing Base and Competitors
Table 94. LIMOR Major Business
Table 95. LIMOR Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 96. LIMOR Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. LIMOR Recent Developments/Updates
Table 98. ME VAC Basic Information, Manufacturing Base and Competitors
Table 99. ME VAC Major Business
Table 100. ME VAC Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 101. ME VAC Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. ME VAC Recent Developments/Updates
Table 103. Agrovet Basic Information, Manufacturing Base and Competitors
Table 104. Agrovet Major Business
Table 105. Agrovet Foot and Mouth Disease (FMD) Vaccines Product and Services
Table 106. Agrovet Foot and Mouth Disease (FMD) Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Agrovet Recent Developments/Updates
Table 108. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Manufacturer (2018-2023) & (M Doses)
Table 109. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 110. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Manufacturer (2018-2023) & (USD/K Doses)
Table 111. Market Position of Manufacturers in Foot and Mouth Disease (FMD) Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 112. Head Office and Foot and Mouth Disease (FMD) Vaccines Production Site of Key Manufacturer
Table 113. Foot and Mouth Disease (FMD) Vaccines Market: Company Product Type Footprint
Table 114. Foot and Mouth Disease (FMD) Vaccines Market: Company Product Application Footprint
Table 115. Foot and Mouth Disease (FMD) Vaccines New Market Entrants and Barriers to Market Entry
Table 116. Foot and Mouth Disease (FMD) Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 117. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 118. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 119. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 120. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 121. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Region (2018-2023) & (USD/K Doses)
Table 122. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Region (2024-2029) & (USD/K Doses)
Table 123. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 124. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 125. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 126. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 127. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Type (2018-2023) & (USD/K Doses)
Table 128. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Type (2024-2029) & (USD/K Doses)
Table 129. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 130. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 131. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 132. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 133. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Application (2018-2023) & (USD/K Doses)
Table 134. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Application (2024-2029) & (USD/K Doses)
Table 135. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 136. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 137. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 138. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 139. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 140. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 141. North America Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 142. North America Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 143. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 144. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 145. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 146. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 147. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 148. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 149. Europe Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 150. Europe Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 151. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 152. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 153. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 154. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 155. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 156. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 157. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 158. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 159. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 160. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 161. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 162. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 163. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 164. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 165. South America Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 166. South America Foot and Mouth Disease (FMD) Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 167. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 168. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 169. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 170. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 171. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 172. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 173. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 174. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 175. Foot and Mouth Disease (FMD) Vaccines Raw Material
Table 176. Key Manufacturers of Foot and Mouth Disease (FMD) Vaccines Raw Materials
Table 177. Foot and Mouth Disease (FMD) Vaccines Typical Distributors
Table 178. Foot and Mouth Disease (FMD) Vaccines Typical Customers
List of Figures
Figure 1. Foot and Mouth Disease (FMD) Vaccines Picture
Figure 2. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Emergency Vaccines Examples
Figure 5. Conventional Vaccines Examples
Figure 6. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Application in 2022
Figure 8. Cattle Examples
Figure 9. Pig Examples
Figure 10. Sheep and Goat Examples
Figure 11. Others Examples
Figure 12. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity (2018-2029) & (M Doses)
Figure 15. Global Foot and Mouth Disease (FMD) Vaccines Average Price (2018-2029) & (USD/K Doses)
Figure 16. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Foot and Mouth Disease (FMD) Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Foot and Mouth Disease (FMD) Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Foot and Mouth Disease (FMD) Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Type (2018-2029) & (USD/K Doses)
Figure 31. Global Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Foot and Mouth Disease (FMD) Vaccines Average Price by Application (2018-2029) & (USD/K Doses)
Figure 34. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 54. China Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Foot and Mouth Disease (FMD) Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Foot and Mouth Disease (FMD) Vaccines Market Drivers
Figure 75. Foot and Mouth Disease (FMD) Vaccines Market Restraints
Figure 76. Foot and Mouth Disease (FMD) Vaccines Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Foot and Mouth Disease (FMD) Vaccines in 2022
Figure 79. Manufacturing Process Analysis of Foot and Mouth Disease (FMD) Vaccines
Figure 80. Foot and Mouth Disease (FMD) Vaccines Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

jiaGou

Add To Cart

gouMai

Buy Now